BRCA2 and ovarian carcinoma: Finally, we compared the number of potentially pathogenic variants identified by each variant caller in five genes that are frequently mutated in cancer, particularly in ovarian cancer: BRCA1, BRCA2, KRAS, PIK3CA and TP53 [32, 33].